Recap: UroGen Pharma Q1 Earnings

UroGen Pharma URGN reported its Q1 earnings results on Thursday, May 11, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

UroGen Pharma beat estimated earnings by 2.26%, reporting an EPS of $-1.3 versus an estimate of $-1.33.

Revenue was up $3.63 million from the same period last year.

Last quarter the company missed on EPS by $0.15 which was followed by a 8.9% drop in the share price the next day.

Here's a look at UroGen Pharma's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-1.07	-1.16	-1.23	-1.33
EPS Actual	-1.22	-1.13	-1.18	-1.25
Revenue Estimate	18.51M	20.15M	17.23M	15.18M
Revenue Actual	18.09M	16.10M	16.60M	13.56M

To track all earnings releases for UroGen Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.